Form 4: Centene Executive Reports Stock Transactions

Michael A. Carson, Group President of Medicare & Specialty at Centene Corp, reported transactions involving common stock and phantom stock.

Summary

• Michael A. Carson, Group President of Medicare & Specialty at Centene Corp (CNC), has filed a Form 4 detailing changes in his beneficial ownership of company securities.
• The filing indicates a transaction on May 22, 2026, involving phantom stock acquired through a deferred compensation plan.
• Carson's ownership includes 113,747 shares of restricted stock units and performance stock units, reported at target performance levels, which are subject to vesting requirements.
• Additionally, 825 shares of common stock are beneficially owned indirectly by his spouse.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it reports routine insider transactions without indicating significant positive or negative developments for the company.

Positives

• Executive participation in deferred compensation plans suggests continued commitment to the company.
• Ownership of restricted stock units and performance stock units, even if subject to vesting, indicates alignment with long-term company performance.

Negatives

• The filing does not provide details on the specific value or performance of the restricted stock units and performance stock units.
• The indirect ownership of 825 shares by a spouse is a minor detail but represents a portion of ownership not directly controlled by the reporting person.

Risks

• Vesting requirements for restricted stock units and performance stock units could lead to forfeiture if performance targets are not met.
• The value of phantom stock is tied to the fair market value of Centene common stock, exposing it to market volatility.

Future Outlook

The filing does not contain forward-looking statements or guidance. It solely reports on past transactions and current beneficial ownership.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for executives and directors, providing transparency into insider stock transactions. This filing for a Centene executive is typical for a large, publicly traded healthcare company.

Comparison to Industry Standards

• This filing is a routine Form 4, which is a standard requirement for all U.S. public company insiders under SEC regulations.
• The structure and content align with typical insider transaction reports filed by executives at companies like UnitedHealth Group (UNH) or Anthem (now Elevance Health - ELV).

Stakeholder Impact

• Shareholders gain insight into executive stock holdings and transactions, contributing to transparency.
• Employees may view executive participation in deferred compensation plans as a sign of management's long-term commitment.

Next Steps

• Vesting of restricted stock units and performance stock units, contingent on meeting performance targets.
• Settlement of phantom stock in cash or other non-Company securities upon Mr. Carson's termination or elected date.

Key Dates

Keywords

Centene Corp, CNC, Form 4, SEC filing, beneficial ownership, stock transaction, phantom stock, restricted stock units, performance stock units, deferred compensation, Michael A. Carson